QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stifel-reinstates-buy-on-black-diamond-therapeutic-announces-8-price-target

Stifel analyst Laura Prendergast reinstates Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and announces $8 price target.

 4-biotechnology-stocks-lead-momentum-gains-amid-strong-technicals

4 biotech stocks—ALDX, ALEC, BDTX, CHRS—show strong week-on-week momentum ranking gains and improving technical indicators.

 guggenheim-initiates-coverage-on-black-diamond-therapeutic-with-buy-rating-announces-price-target-of-8

Guggenheim analyst Brad Canino initiates coverage on Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy rating and announces...

 hc-wainwright--co-maintains-buy-on-black-diamond-therapeutic-lowers-price-target-to-10

HC Wainwright & Co. analyst Robert Burns maintains Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and lowers the pri...

 raymond-james-reinstates-outperform-on-black-diamond-therapeutic-announces-11-price-target

Raymond James analyst Sean McCutcheon reinstates Black Diamond Therapeutic (NASDAQ:BDTX) with a Outperform and announces $11...

 black-diamond-therapeutic-q1-eps-098-beats-002-estimate-sales-7000m

Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimat...

 black-diamond-therapeutics-inks-licensing-pact-with-french-pharma-firm-servier-for-its-early-stage-cancer-drug-worth-over-700-million

Servier announces a strategic worldwide licensing agreement for Black Diamond Therapeutics' BDTX-4933 for solid tumors for ...

Core News & Articles
Market-Moving News for March 19th
03/19/2025 11:23:47

SIG: 18% | Signet Jewelers shares are trading higher after the company reported better-than-expected Q4 adjusted EPS and sales....

 hc-wainwright--co-maintains-buy-on-black-diamond-therapeutic-raises-price-target-to-12

HC Wainwright & Co. analyst Robert Burns maintains Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and raises the pri...

 stifel-maintains-buy-on-black-diamond-therapeutic-lowers-price-target-to-15

Stifel analyst Bradley Canino maintains Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and lowers the price target from ...

 black-diamond-therapeutic-q4-eps-028-beats-031-estimate

Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimat...

 hc-wainwright--co-reiterates-buy-on-black-diamond-therapeutic-maintains-11-price-target

HC Wainwright & Co. analyst Robert Burns reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and maintains $11...

 black-diamond-therapeutic-q3-2024-gaap-eps-028-beats-038-estimate

Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimat...

 hc-wainwright--co-reiterates-buy-on-black-diamond-therapeutic-maintains-11-price-target

HC Wainwright & Co. analyst Robert Burns reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and maintains $11...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION